NEW YORK (GenomeWeb News) – Optibrium and Molecular Networks today said that they will share complementary technology platforms for the drug discovery market.
The collaboration will integrate Molecular Networks' 3D structure generator, Corina, into Optibrium's StarDrop, a platform for guiding compound selection and design.
According to the firms, Corina is used within StarDrop's predictive P450 metabolism models, which identify metabolic liabilities of candidate molecules against the major cytochrome P450 enzymes.
"The seamless integration of CORINA within StarDrop has enabled our P450 metabolism models to provide more reliable data in support of the drug design and optimisation process," Matthew Segall, CEO of Cambridge, UK-based Optibrium, said in a statement. "We are looking forward to providing access to more of Molecular Network's chemoinformatics tools through StarDrop to further benefit our customers."
Financial and further terms of the alliance were not disclosed.